PATH-54. MULTI-DIMENSIONAL MOLECULAR CHARACTERIZATION OF PATIENT-MATCHED MEDULLOBLASTOMA AT DIAGNOSIS AND RELAPSE

INTRODUCTION: Recurrent medulloblastoma (MB) confers an abysmal prognosis with ~10% 5-year overall survival. Optimal treatment paradigms for relapsed disease are largely unknown. Conservation of molecular subgroup at relapse has been described and divergent clonal evolution implicated, yet multi-dim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Kumar, Rahul, Deng, Maximilian, Smith, Kyle, Liu, Anthony P Y, Rudneva, Vasilisa, Dhall, Girish, Kleese, Laura, Bowers, Daniel, Chintagumpala, Murali, Leary, Sarah, Nazarian, Javad, Orr, Brent, Robinson, Giles, Pfister, Stefan, Korshunov, Andrey, Gajjar, Amar, Jones, David, Northcott, Paul
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Molecular Pathology and Classification - Adult and Pediatric
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847752/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.649
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars